250 related articles for article (PubMed ID: 20833872)
21. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
22. Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity.
Gaudette DC; Holub BJ
Lipids; 1990 Mar; 25(3):166-9. PubMed ID: 2139712
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.
Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N
Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576
[TBL] [Abstract][Full Text] [Related]
24. JJK694, a synthesized obovatol derivative, inhibits platelet activation by suppressing cyclooxygenase and lipoxygenase activities.
Yu JY; Lee JJ; Jung JK; Min YK; Kim TJ; Ma JY; Lee MY; Yun YP
Biosci Biotechnol Biochem; 2012; 76(11):2038-43. PubMed ID: 23132562
[TBL] [Abstract][Full Text] [Related]
25. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
[TBL] [Abstract][Full Text] [Related]
26. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
[TBL] [Abstract][Full Text] [Related]
27. Antiplatelet effect of phloroglucinol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang MC; Chang HH; Chan CP; Chou HY; Chang BE; Yeung SY; Wang TM; Jeng JH
Toxicol Appl Pharmacol; 2012 Sep; 263(3):287-95. PubMed ID: 22789837
[TBL] [Abstract][Full Text] [Related]
28. In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets--effect on aggregation.
Croset M; Lagarde M
Thromb Haemost; 1986 Aug; 56(1):57-62. PubMed ID: 3022414
[TBL] [Abstract][Full Text] [Related]
29. The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro.
Yuan J; Akiyama M; Nakahama K; Sato T; Uematsu H; Morita I
Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):85-90. PubMed ID: 20394833
[TBL] [Abstract][Full Text] [Related]
30. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
Heinroth I; Block HU; Mest HJ
Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
[TBL] [Abstract][Full Text] [Related]
31. Isomers of trans fatty acids modify the activity of platelet 12-P lipoxygenase and cyclooxygenase/thromboxane synthase.
Stachowska E; Dołegowska B; Olszewska M; Gutowska I; Chlubek D
Nutrition; 2004 Jun; 20(6):570-1. PubMed ID: 15165621
[TBL] [Abstract][Full Text] [Related]
32. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
33. The structure-activity relationship of lipoxygenase products of long-chain polyunsaturated fatty acids: effects on human platelet aggregation.
Karanian JW; Kim HY; Salem N
Lipids; 1996 Mar; 31 Suppl():S305-8. PubMed ID: 8729140
[TBL] [Abstract][Full Text] [Related]
34. Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes.
Francesconi M; Scapin M; Casonato A; Girolami A; Deana R
Thromb Res; 2000 Nov; 100(4):293-303. PubMed ID: 11113273
[TBL] [Abstract][Full Text] [Related]
35. Effect of prostanoids and their precursors on the aggregation of rainbow trout thrombocytes.
Hill DJ; Hallett MB; Rowley AF
Am J Physiol; 1999 Mar; 276(3):R659-64. PubMed ID: 10070125
[TBL] [Abstract][Full Text] [Related]
36. Novel effects of epoxyeicosatrienoic acid isomers: inhibition of platelet aggregation and cyclooxygenase activity.
Fitzpatrick FA; Ennis MD; Baze ME
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():109-14. PubMed ID: 2959037
[No Abstract] [Full Text] [Related]
37. Novel proresolving aspirin-triggered DHA pathway.
Serhan CN; Fredman G; Yang R; Karamnov S; Belayev LS; Bazan NG; Zhu M; Winkler JW; Petasis NA
Chem Biol; 2011 Aug; 18(8):976-87. PubMed ID: 21867913
[TBL] [Abstract][Full Text] [Related]
38. On the structure and synthesis of neuroprotectin D1, a novel anti-inflammatory compound of the docosahexaenoic acid family.
Butovich IA
J Lipid Res; 2005 Nov; 46(11):2311-4. PubMed ID: 16150835
[TBL] [Abstract][Full Text] [Related]
39. Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances.
Whitaker MO; Wyche A; Fitzpatrick F; Sprecher H; Needleman P
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5919-23. PubMed ID: 230492
[TBL] [Abstract][Full Text] [Related]
40. Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function.
Rao GH; Radha E; White JG
Biochem Biophys Res Commun; 1983 Dec; 117(2):549-55. PubMed ID: 6229254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
